The World Market for Companion Diagnostics
The World Market for Companion Diagnostics examines revenues for companion diagnostic and personalized medicine diagnostics. Market analysis in this market review includes regional coverage – North America, Europe, rest of world – of the world IVD companion diagnostics test market (in vitro diagnostic kits) for 2015-2020, coverage by disease segment – cancer and other – of the world IVD companion diagnostics test market for 2015, and coverage of the worldwide companion diagnostics test services market for 2015 and 2020. The report reviews emerging and current applications of personalized medicine, including selected major biomarkers in oncology personalized medicine tests and selected companies with personalized medicine tests for oncology, cardiovascular disease/disorders, and neurological disorders. Pfizer, Inc., Novartis AG, Roche (F. Hoffmann-La Roche Ltd.), Merck & Co., Inc., and GlaxoSmithKline plc are among the manufacturers analyzed of the selected pharmaceutical companies that are active in the fields of companion diagnostics or personalized medicine.